Organization :   Ludwig Institute for Cancer Research, Uppsala, SE-751 24, Sweden

INHIBITION OF TGFβ SIGNALING AND ITS IMPLICATIONS IN ANTICANCER TREATMENTSINHIBITION OF TGFβ SIGNALING AND ITS IMPLICATIONS IN ANTICANCER TREATMENTS
Authors :Calone I. Souchelnytskyi S. Vol. 34, No. 1 / Views: 6423
Proteomic Strategy for Detection of Circulating Tumor Cell Surface Antigens
Authors :Souchelnytskyi S. Mints M. Vol. 33, No. 3 / Views: 1296
Endometrial cancer and application of proteomics
Authors :Souchelnytskyi S. Andersson S. Mints M. Attarha S. Vol. 33, No. 3 / Views: 508
Comments on the cross-talk of TGFβ and EGF in cancer
Authors :Souchelnytskyi S. Jia M. Vol. 33, No. 3 / Views: 3028
Current status and challenges of personalized treatment of cancer: view inspired by the workshop
Author :Souchelnytskyi S. Vol. 33, No. 3 / Views: 217